What You Should Know:
- Virta is expanding its suite of treatment options to
include prediabetes reversal, obesity reversal, and type 2 diabetes management.
- By making this crucial expansion, Virta can scale its
treatment to support the tens of millions of additional patients with
prediabetes and obesity, as provide an on-ramp to reversal for those with T2D
that aren’t yet ready to reverse.
Virta Health, the
leader in type 2 diabetes reversal, today introduced the addition
Read More
Diabetes Management Platform | Type 1 & 2 Diabetes Patients | News, Analysis, Insights - HIT Consultant
Medtronic Acquires Smart Insulin Pen Company Companion Medical
What You Should Know:
- Today, Medtronic announced that it will
acquire Companion Medical, the manufacturer of InPen, a smart insulin pen
system paired with an integrated diabetes management app.
- The addition of Companion’s InPen system builds
upon Medtronic's strategic acquisitions of Nutrino and Klue to further
improve overall automated decision-making capabilities and optimizes dosing
decisions using algorithms and AI for patients.
Medtronic,
today announced the
Read More
DreaMed Diabetes Supports Research on Efficacy of Virtual Diabetes Care
What You Should Know:
- DreaMed Diabetes, the developer of personalized, AI-based diabetes management solutions, will participate in a clinical study, led by Jaeb Center for Health Research Foundation, to evaluate the efficacy of virtual treatment for diabetes patients. The research is funded by a grant from The Leona M. and Harry B. Helmsley Charitable Trust.
- DreaMed uses AI-powered technology to seamlessly treat
patients remotely with its virtual diabetes management service by
Read More
Current Health, Dexcom Partner to Deliver Continuous, Remote Glucose Monitoring
What You Should Know:
- Current Health has partnered with Dexcom to add continuous
glucose monitoring (CGM) capabilities to its remote patient monitoring (RPM)
platform – enhancing care and improving outcomes for diabetics.
- Dexcom CGM data will transmit directly into the Current
Health wearable and platform for review by the care management and clinical
teams, improving post-discharge and chronic care of diabetes patients outside
the hospital.
- Through this partnership, Current
Read More
COVID-19: Glooko Offers Free Remote Care to Medical Clinics and People with Diabetes
What You Should Know:
- Glooko today announced that during the COVID-19 pandemic they are taking action to serve the global diabetes community by providing a no-charge remote care solution that provides live patient-to-clinician connectivity.
- To minimize the risk to people with diabetes during this time by broadening access to a remote medical appointment with healthcare providers, Glooko is offering its secure, privacy-protected remote care solution at no charge to medical clinics and
Read More
Welldoc, Redox Partner for Bidrectional EHR Integration with BlueStar App
- Welldoc and Redox announce a partnership to ensure bidirectional integration with EHR with Welldoc's digital health solution for diabetes management, BlueStar.
- This partnership will allow providers to receive and review insights about users of Welldoc's BlueStar digital health app for diabetes management directly within their EHR at the point of care.
Welldoc, a digital health
company revolutionizing chronic disease management, announced today its
strategic partnership
Read More
Livongo, VSP Vision Care Partner to Improve Eye Care for People Living with Diabetes
- Livongo announced a partnership with VSP Vision Care to offer mutual Members resources and insights to manage chronic conditions and vision care on one platform. - People with diabetes and prediabetes have an increased risk of vision complications and vision loss and by offering them resources to better manage their eye health on the Livongo platform, we can effectively close gaps in care. Livongo Health, Inc., an Applied Health Signals company empowering people with chronic conditions to live
Read More
Livongo Inks $50M Diabetes Contract Through Federal Employees Health Benefits Program (FEHBP)
- Livongo has been awarded a contract to provide the Livongo for Diabetes solution to eligible members covered by the Federal Employees Health Benefits Program (FEHBP ) under one health plan.- The contract is Livongo’s biggest contract in company history and will account for $20-25M in revenue in 2020 and $30-35M in revenue for 2021, representing a total of $50-60M including both years.- The announcement reflects Livongo’s overall market traction and how they are expanding from working primarily
Read More
Drugmaker Bayer to License One Drop’s Digital Diabetes Management Platform, Leads $40M Series B Funding
- Drugmaker Bayer leads One Drop’s $40M Series B funding round and enters commercial agreement to license One Drop's digital diabetes management platform in its global bio-digital efforts in therapeutic areas. - Bayer will leverage One Drop's data science and predictive capabilities, and harness its mobile platform to deliver innovative bio-digital solutions across a broad array of therapeutic areas.- One Drop provides personalized health programs to drive sustainable behavior change as part of
Read More
Abbott and Sanofi Partner to Integrate Glucose Sensing and Insulin Data
- Abbott (ABT) and Sanofi partner to integrate to developing tools that combine the FreeStyle Libre technology with Sanofi′s insulin dosing information for future smartpens, insulin titration apps and cloud software. - The integration will enable both people with diabetes and their doctors to make better-informed treatment decisions around medication, nutrition, and lifestyle.Abbott (ABT) and Sanofi, today announced they are partnering to integrate glucose sensing and insulin delivery
Read More
